2015 Concordia Healthcare



in september, condordia paid european private equity firm cinven $3.5 billion in cash , shares uk-based global out-of-patent prescription pharmaceuticals firm amdipharm mercury - abbreviated amco. deal uniquely position combined company leading, international pharmaceutical company extensive geographic reach , said concordia chief executive mark thompson. 2015 year-over-year revenue growth of $289 million or increase of 276 per cent


year-over-year adjusted ebitda1 growth of $206 million or increase of 347 per cent








Comments

Popular posts from this blog

Gigantomastia Breast hypertrophy

Release information Conversations with Other Women

Operation Unified Task Force